WASHINGTON, DC – SEPTEMBER 21, 2010 – A new drug-eluting stent design demonstrated superiority over a traditional drug-eluting stent at 6 months, according to a study led by Laura Mauri, MD, Associate ...

A new drug-eluting stent design demonstrated superiority over a traditional drug-eluting stent at 6 months, according to a new study. A new drug-eluting stent design demonstrated superiority over a ...

Each year, about 250,000 Americans undergo sleeve gastrectomy, one of the most common weight-loss operations in the United States. For most patients, recovery is uneventful. But for a small share - ...

Using computer models to study the strengths and weaknesses of different stent structures could help manufacturers optimize stent design and help doctors choose the right stents for their patients.

In the quest for increasingly thinner, smaller, and more-flexible stents, medical device designers may have compromised structural integrity in some current-generation drug-eluting stents (DES). And ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Results of a recent meta-analysis suggest that an ...

Vascular surgeon Pat Kelly of Sanford Health knew his patients were doing better with the stent graft he designed, but he wanted a better understanding of the mechanics before testing the device more ...

When the first drug-eluting stents were implanted in 1999, researchers and clinical cardiologists welcomed this groundbreaking innovation. In this platform, stents that elute either a cytotoxic ...

Drug-eluting stents are small, wire scaffolds that are inserted into coronary arteries that have become narrow due to the development of atherosclerosis. The stent helps to hold the artery open and ...

Drug-eluting stents (DES) have revolutionized the practice of interventional cardiology over the past decade. Although their efficacy has never been called into question, concerns have been raised ...